The recent scandal surrounding former Nvidia CEO Jensen Huang’s resignation has placed VP Kimberly Powell, who leads the company’s healthcare and life sciences business focused on AI-accelerated medical imaging, drug discovery, and related platforms, under scrutiny. Reports of her alleged relationship with Huang, who resigned amid multiple extramarital affairs including one tied to a suspected foreign intelligence probe, introduced questions about workplace policy violations given her direct reporting line to him. No official announcements confirm her resignation or removal as of mid-November 2026, with her status remaining unclear despite the leadership transition to interim CEO Colette Kress. Nvidia’s upcoming fiscal third-quarter earnings on November 17 could clarify any internal review or personnel decisions amid ongoing board oversight.